OpenVSafe by OpenVAERS
Search V-safe

C4E-90831-30591

2 vaccinations 3 coded responses 16 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
606 / IL
Registered
2021-01-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-25
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-05
    Registered in v-safe
  3. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-08
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  6. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches
    Adult check-in
  8. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Nausea
    Adult check-in
  10. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-15
    Survey response — 3 months, dose 2
    MedDRA: Gestational hypertension, Pre-eclampsia — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Gestational hypertension/pre eclampsia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-15
    Report sent to call center — 3 months, dose 2
    Be unable to work · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-05-27
  20. 2021-07-15
    Survey response — 6 months, dose 2
    MedDRA: Haemorrhage, Hypertension, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Pre eclampsia, postpartum hemorrhage, ongoing high blood pressure
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  21. 2021-07-15
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  22. 2021-07-21
  23. 2021-07-24
  24. 2022-01-16
    Survey response — 12 months, dose 2
    MedDRA: Arthritis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Auto immune inflammatory arthritis
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-01-16
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  26. 2022-01-18

Vaccinations

DoseDateManufacturerCo-administered
12020-12-25Pfizer-BioNTech
22021-01-14Pfizer-BioNTech

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 7 — 3 months, dose 2

2021-04-15

Symptoms: Gestational hypertension/pre eclampsia

Release 9 — 6 months, dose 2

2021-07-15

Symptoms: Pre eclampsia, postpartum hemorrhage, ongoing high blood pressure

Release 10 — 12 months, dose 2

2022-01-16

Symptoms: Auto immune inflammatory arthritis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthritis · · ✓
SDGestational hypertension ✓ ✓ ✓
SDHaemorrhage ✓ · ✓
SDHypertension ✓ · ✓
SDPre-eclampsia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release